Table 4.

Average duration of each estimated gait phase vs. Perry's gait cycle (left cycles). Avg, average.

Subjects	Trials	LR (ms)	MSt (ms)	TSt (ms)	PSw (ms)	Sw (ms)
Subject A	Trial 1	10	115	13	−98	5
	Trial 2	−40	140	5	−86	−21
	Trial 3	−71	148	8	−97	20
Subject B	Trial 1	34	38	15	−42	−44
	Trial 2	12	39	−3	−61	−40
	Trial 3	59	29	5	-45	−46
Subject C	Trial 1	−14	101	−20	−50	8
	Trial 2	−35	99	20	−75	5
	Trial 3	−29	99	−11	−52	0
Subject D	Trial 1	23	34	−6	−56	−39
	Trial 2	32	37	11	−45	−43
	Trial 3	47	41	12	−50	−40
Subject E	Trial 1	−25	69	−18	−38	−9
	Trial 2	−29	84	−14	−48	−12
	Trial 3	−13	80	4	−44	−1
	Avg (±SD)	−3 (±36)	77 (±38)	1 (±12)	−59 (±19)	−17 (±22)